(1). With appropriate initial treatment, the majority of those patients can expect to achieve
good disease-specific outcomes. However, up to 30% of patients (2) will suffer persistent …

The diagnosis and treatment of recurrent or persistent papillary carcinoma of the thyroid can
pose significant clinical dilemmas. The tumor generally has a relatively indolent biology; …

Opinion statement The incidence of epithelial derived thyroid cancer (papillary thyroid
cancer [PTC] and follicular thyroid cancer, known collectively as differentiated thyroid …

The last 10 years have seen a major paradigm shift in the management of thyroid cancer,
with greater reliance on serum thyroglobulin and neck ultrasonography, and less emphasis …

Papillary and follicular thyroid cancer, together referred to as differentiated thyroid cancer
(DTC), is usually curable when discovered at an early stage. Its management, however, is …

I greatly appreciate the opportunity to serve as the 31st President of the American
Association of Endocrine Surgeons. Our organization enjoys a rich tradition of academic …

Background While the most suitable approach for treating persistent/recurrent papillary
thyroid carcinoma (PTC) remains controversial, reoperation may be considered an effective …

Historically, thyroid cancers have received relatively little attention from the medical
oncology community. As recently as the 2005 Annual Meeting of the American Society of …

Clinical members of the American Thyroid Association were surveyed in regard to their
diagnostic assessment, treatment, and long term assessment of differentiated papillary …

This article presents an overview of medical management of persistent or recurrent
differentiated thyroid cancer, in particular focusing on monitoring strategy and treatment …